Skip to main content

Ropivacaine Injection

Last Updated: January 25, 2023
Status: Current

Products Affected - Description
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0285-10
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 25 count, NDC 63323-0285-13
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL premixed bag, 1 count, NDC 63323-0285-61
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0285-20
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL premixed bag, 1 count, NDC 63323-0285-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0286-00
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0286-20
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0286-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL Steripak plastic ampule, 5 count, NDC 63323-0286-31
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL vial, 25 count, NDC 63323-0286-35
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL vial, 25 count, NDC 63323-0287-21
    • Ropivacaine injection, Akorn, 5 mg/mL, 30 mL vial, 1 count, NDC 17478-0081-30
    • Ropivacaine injection, Baxter, 10 mg/mL, 20 mL vial, 10 count, NDC 43066-0027-10
    • Ropivacaine injection, Baxter, 2 mg/mL, 20 mL vial, 10 count, NDC 43066-0015-10
    • Ropivacaine injection, Baxter, 5 mg/mL, 20 mL vial, 10 count, NDC 43066-0019-10
    • Ropivacaine injection, Baxter, 5 mg/mL, 30 mL vial, 10 count, NDC 43066-0023-10
    • Ropivacaine injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9263-10
    • Ropivacaine injection, Pfizer, 10 mg/mL, 10 mL vial, 10 count, NDC 00409-9303-10 - discontinued
    • Ropivacaine injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-9303-20 - discontinued
    • Ropivacaine injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-9300-10 - discontinued
    • Ropivacaine injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-9300-20 - discontinued
    • Ropivacaine injection, Pfizer, 5 mg/mL, 30 mL vial, 10 count, NDC 00409-9301-30 - discontinued
    • Ropivacaine injection, Pfizer, 7.5 mg/mL, 20 mL vial, 10 count, NDC 00409-9302-20 - discontinued
    • Ropivacaine injection, Sagent, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0652-82
Reason for the Shortage
    • Akorn had ropivacaine on shortage due to increased demand.
    • Baxter has ropivacaine on shortage due to increase demand.
    • Eugia has ropivacaine available.
    • Fresenius Kabi has Naropin on shortage due to increased demand and manufacturing delays.
    • Pfizer discontinued ropivacaine in August 2022.
    • Sagent did not provide a reason for the shortage.
    • Somerset Therapeutics has ropivacaine 5 mg/mL 30 mL vials available.
Available Products
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0288-10
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 25 count, NDC 63323-0288-11
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0288-20
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 25 count, NDC 63323-0288-21
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0285-65
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 25 count, NDC 63323-0285-23
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0285-64
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 25 count, NDC 63323-0286-23
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0287-20
    • Ropivacaine injection, Eugia US, 10 mg/mL, 10 mL vial, 25 count, NDC 55150-0200-10
    • Ropivacaine injection, Eugia US, 10 mg/mL, 20 mL vial, 25 count, NDC 55150-0201-20
    • Ropivacaine injection, Eugia US, 2 mg/mL, 100 mL infusion bottle, 25 count, NDC 55150-0196-99
    • Ropivacaine injection, Eugia US, 2 mg/mL, 20 mL vial, 25 count, NDC 55150-0195-20
    • Ropivacaine injection, Eugia US, 5 mg/mL, 20 mL vial, 25 count, NDC 55150-0197-20
    • Ropivacaine injection, Eugia US, 5 mg/mL, 30 mL vial, 25 count, NDC 55150-0198-30
    • Ropivacaine injection, Eugia US, 7.5 mg/mL, 20 mL vial, 25 count, NDC 55150-0199-20
    • Ropivacaine injection, Sagent, 2 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0671-82
    • Ropivacaine injection, Sagent, 2 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0671-87
    • Ropivacaine injection, Sagent, 5 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0652-87
    • Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 10 count, NDC 70069-0062-10
    • Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 25 count, NDC 70069-0062-25
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 1 count, NDC 70069-0064-01
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 10 count, NDC 70069-0064-10
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 25 count, NDC 70069-0064-25

Estimated Resupply Dates

    • Baxter has ropivacaine 2 mg/mL 20 mL vials, 5 mg/mL 20 mL and 30 mL vials, and 10 mg/mL 20 mL vials available limited supply.
    • Fresenius Kabi has Naropin 2 mg/mL 10 mL and 20 mL Steripak ampules on back order and the company cannot estimate a release date. The 2 mg/mL 10 mL vials are on back order and the company estimates a release date of early-March 2023. The 2 mg/mL 100 mL and 200 mL premixed bags are on back order and the company cannot estimate a release date. The 5 mg/mL 30 mL vials are on back order and the company estimates a release date of late-January 2023. The 5 mg/mL 20 mL and 30 mL Steripak ampules are on back order and the company cannot estimate a release date. The 5 mg/mL 200 mL bottles are on back order and the company estimates a release date of late-January 2023. The 7.5 mg/mL 20 mL vials are on back order and the company estimates a release date of late-February 2023. The 10 mg/mL 20 mL Steripak ampules are on back order and the company cannot estimate a release date.
    • Hikma has ropivacaine 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date.
    • Sagent has ropivacaine 5 mg/mL 100 mL premixed bags on allocation.

Updated

Updated January 25, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer